In subsequent studies, we will use a variety of assay methods, such as RNA immunoprecipitation and RNA pull-down assays, to further verify the direct or indirect interaction of ILF3-AS1, miR-212 and SMAD1 in NSCLC. This evidence concerns the gene SMAD1 and non-small cell lung carcinoma.